SCHEMBL1578048

SCHEMBL1578048

CCN1CCNCC1OC(c1ccc(O)cc1)c1ccc(O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.37
LMNA P02545 1/20 0.37
ESR1 P03372 1/20 0.37
CYP1A2 P05177 1/20 0.37
PGR P06401 1/20 0.37
CHRM2 P08172 1/20 0.37
CYP3A4 P08684 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
AR P10275 1/20 0.37
CYP2D6 P10635 1/20 0.37
MAPT P10636 1/20 0.37
CHRM1 P11229 1/20 0.37
CYP2C9 P11712 1/20 0.37
ALOX15 P16050 1/20 0.37
DRD1 P21728 1/20 0.37
TBXA2R P21731 1/20 0.37
PTGS1 P23219 1/20 0.37
SLC6A2 P23975 1/20 0.37
CYP2C19 P33261 1/20 0.37
ADRA1A P35348 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6255525 0.88 SIGMAR1 (0.43) CHRM2CYP2D6CHRM1DRD1SLC6A2
SCHEMBL1577933 0.86 SIGMAR1 (0.46) LMNACYP1A2CHRM2CYP2D6CHRM1
SCHEMBL8097767 0.78 CHRNA7 (0.44) LMNAESR1CHRM2CYP3A4CYP2D6
SCHEMBL27712059 0.75 SMN1; SMN2 (0.31) TDP1
SCHEMBL1563070 0.70 HTR2A (0.30)
SCHEMBL8642038 0.69 SLC6A3 (0.49) LMNACYP1A2CHRM2CYP2D6CHRM1
SCHEMBL27889106 0.69 HRH1 (0.40) TDP1SLC6A2CYP2C19SLC6A3
SCHEMBL8647651 0.67 SLC6A3 (0.47) LMNACYP1A2CHRM2CYP2D6CHRM1
SCHEMBL8650227 0.66
SCHEMBL7584443 0.66 TDP1 (0.40) TDP1ESR1DRD1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680097-B2 Benzothiophene alkanol piperazine derivatives and their use as antidepressant CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO. LTD. (CN) 2014-03-25 US disclosed
US-20110118263-A1 BENZOTHIOPHENE ALKANOL PIPERAZINE DERIVATIVES AND THEIR USE AS ANTIDEPRESSANT CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO. LTD. (CN) 2011-05-19 US disclosed
EP-2311828-A1 BENZOTHIOPHENE ALKANOL PIPERAZINE DERIVATIVES AND THEIR USE AS ANTIDEPRESSANT CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. (CN) 2011-04-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118263-A1 BENZOTHIOPHENE ALKANOL PIPERAZINE DERIVATIVES AND THEIR USE AS ANTIDEPRESSANT TPH1, HTR1A, TPH2 TDP1 851/4885LMNA 3558/4885ESR1 1006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.